Lv2
140 积分 2025-04-11 加入
Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention
8天前
已完结
Current developments in gastric cancer: from molecular profiling to treatment strategy
9天前
已完结
Pembrolizumab
11天前
已关闭
HER-2 positive gastric cancer: Current targeted treatments
14天前
已完结
Current developments in gastric cancer: from molecular profiling to treatment strategy
14天前
已完结
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial
15天前
已完结
Human Epidermal Growth Factor Receptor 2 Positive Advanced Gastric or Esophagogastric Adenocarcinoma: Reflecting on the Past to Gain a New Insights
17天前
已完结
皖公网安备34019202002308
